M. Kish, Guide to Development of Practice Guidelines, Clinical Infectious Diseases, vol.32, issue.6, pp.851-855, 2001.
DOI : 10.1086/319366

M. Palmert, H. Malin, and P. Boepple, Unsustained or Slowly Progressive Puberty in Young Girls: Initial Presentation and Long-Term Follow-Up of 20 Untreated Patients, Journal of Clinical Endocrinology & Metabolism, vol.84, issue.2, pp.415-423, 1999.
DOI : 10.1210/jc.84.2.415

K. Klein, Precocious Puberty, J Clin Endocrinol Metab, vol.84, pp.411-415, 1999.
DOI : 10.1007/978-3-319-27225-2_2

L. Lazar, A. Pertzelan, and N. Weintrob, Slowly Progressive Puberty Gonadotropin-Suppressive Therapy and Final Height, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.9, pp.4127-4159, 2001.
DOI : 10.1210/jcem.86.9.7852

L. Lazar, A. Padoa, and M. Phillip, Growth Pattern and Final Height after Cessation of Gonadotropin-Suppressive Therapy in Girls with Central Sexual Precocity, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.9, pp.3483-3492, 2007.
DOI : 10.1210/jc.2007-0321

M. Fontoura, R. Brauner, and C. Prevot, Precocious puberty in girls: early diagnosis of a slowly progressing variant., Archives of Disease in Childhood, vol.64, issue.8, pp.1170-1176, 1989.
DOI : 10.1136/adc.64.8.1170

A. Papadimitriou, D. Beri, and A. Tsialla, Early growth acceleration in girls with idiopathic precocious puberty, The Journal of Pediatrics, vol.149, issue.1, pp.43-49, 2006.
DOI : 10.1016/j.jpeds.2006.02.005

M. Zachmann, B. Sobradillo, and M. Frank, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height, J Pediatr. J Pediatr, vol.93126, pp.749-755955, 1978.

R. Kauli, A. Galatzer, and L. Kornreich, Final Height of Girls with Central Precocious Puberty, Untreated versus Treated with Cyproterone Acetate or GnRH Analogue, Hormone Research, vol.47, issue.2, pp.54-61, 1997.
DOI : 10.1159/000185432

S. Heger, C. Partsch, and W. Sippell, Long-Term Outcome after Depot Gonadotropin-Releasing Hormone Agonist Treatment of Central Precocious Puberty: Final Height, Body Proportions, Body Composition, Bone Mineral Density, and Reproductive Function, Journal of Clinical Endocrinology & Metabolism, vol.84, issue.12, pp.4583-90, 1999.
DOI : 10.1210/jc.84.12.4583

J. Carel, M. Roger, and S. Ispas, Final Height after Long-Term Treatment with Triptorelin Slow Release for Central Precocious Puberty: Importance of Statural Growth after Interruption of Treatment, The Journal of Clinical Endocrinology & Metabolism, vol.84, issue.6, pp.1973-1978, 1999.
DOI : 10.1210/jcem.84.6.5647

T. Arrigo, M. Cisternino, and F. Galluzzi, Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty, European Journal of Endocrinology, vol.141, issue.2
DOI : 10.1530/eje.0.1410140

K. Klein, K. Barnes, and J. Jones, Increased Final Height in Precocious Puberty after Long-Term Treatment with LHRH Agonists: The National Institutes of Health Experience, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.10, pp.4711-4717, 2001.
DOI : 10.1210/jcem.86.10.7915

D. Paul, F. Conte, and M. Grumbach, Long term effect of gonadotropin-releasing hormone agonist therapy in children with true precocious puberty treated at a median age of less than 5 years, J Clin Endocrinol Metab, vol.80, pp.546-551, 1995.

D. Mul, S. Bertelloni, and J. Carel, Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results Early puberty is associated with mental health problems in middle adolescence, Horm Res. Soc Sci Med, vol.5857, issue.18, pp.1-71055, 2002.

A. Albanese and N. Hopper, Suppression of menstruation in adolescents with severe learning disabilities, Archives of Disease in Childhood, vol.92, issue.7, pp.629-661, 2007.
DOI : 10.1136/adc.2007.115709

G. Teilmann, M. Boas, and J. Petersen, Early Pituitary-Gonadal Activation before Clinical Signs of Puberty in 5- to 8-Year-Old Adopted Girls: A Study of 99 Foreign Adopted Girls and 93 Controls, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.7, pp.2538-2582, 2007.
DOI : 10.1210/jc.2006-2096

G. Teilmann, C. Pedersen, and N. Skakkebaek, Increased Risk of Precocious Puberty in Internationally Adopted Children in Denmark, PEDIATRICS, vol.118, issue.2, pp.391-400, 2006.
DOI : 10.1542/peds.2005-2939

T. Tuvemo, B. Jonsson, and J. Gustafsson, Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty, Acta Paediatrica, vol.16, issue.44 Suppl, pp.1456-62, 2004.
DOI : 10.1111/j.1651-2227.2004.tb02629.x

K. Berg-kelly and J. Eriksson, Adaptation of adopted foreign children at mid-adolescence as indicated by aspects of health and risk taking--a population study, Eur Child Adolesc Psychiatry, vol.6, pp.199-206, 1997.

D. Mul, H. Versluis-den-bieman, and F. Slijper, Psychological assessments before and after treatment of early puberty in adopted children, Acta Paediatrica, vol.74, issue.Suppl, pp.965-71, 2001.
DOI : 10.1111/j.1651-2227.2001.tb01349.x

E. Neely, R. Hintz, and D. Wilson, Normal ranges for immunochemiluminometric gonadotropin assays, The Journal of Pediatrics, vol.127, issue.1, pp.40-46, 1995.
DOI : 10.1016/S0022-3476(95)70254-7

E. Neely, D. Wilson, and P. Lee, Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty, The Journal of Pediatrics, vol.127, issue.1, pp.47-52, 1995.
DOI : 10.1016/S0022-3476(95)70255-5

E. Resende, B. Lara, and J. Reis, Assessment of Basal and Gonadotropin-Releasing Hormone-Stimulated Gonadotropins by Immunochemiluminometric and Immunofluorometric Assays in Normal Children, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.4, pp.1424-1433, 2007.
DOI : 10.1210/jc.2006-1569

M. Roger, N. Lahlou, and J. Chaussain, Gonadotropin-releasing hormone testing in pediatrics

K. Eckert, D. Wilson, and L. Bachrach, A single-sample, subcutaneous gonadotropinreleasing hormone test for central precocious puberty, Pediatrics, vol.97, pp.517-526, 1996.

L. Garibaldi, T. Aceto, J. Weber, and C. , The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test, J Clin Endocrinol Metab, vol.76, pp.851-857, 1993.

L. Ibanez, N. Potau, and M. Zampolli, Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test, Journal of Clinical Endocrinology & Metabolism, vol.78, issue.1, pp.30-35, 1994.
DOI : 10.1210/jc.78.1.30

O. Pescovitz, K. Hench, and K. Barnes, Premature Thelarche and Central Precocious Puberty: The Relationship Between Clinical Presentation and the Gonadotropin Response to Luteinizing Hormone-Releasing Hormone, The Journal of Clinical Endocrinology & Metabolism, vol.67, issue.3, pp.474-483, 1988.
DOI : 10.1210/jcem-67-3-474

K. Oerter, M. Uriarte, and S. Rose, Gonadotropin secretory dynamics during puberty in normal girls and boys Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche Estradiol levels in prepubertal boys and girls-analytical challenges, J Clin Endocrinol Metab. Eur J Endocrinol. Int J Androl, vol.7115427, issue.35, pp.1251-8891, 1990.

C. Wang, D. Catlin, and L. Demers, Liquid Chromatography-Tandem Mass Spectrometry, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.2, pp.534-577, 2004.
DOI : 10.1210/jc.2003-031287

C. Battaglia, F. Mancini, and G. Regnani, Pelvic ultrasound and color Doppler findings in different isosexual precocities, Ultrasound in Obstetrics and Gynecology, vol.13, issue.3, pp.277-83, 2003.
DOI : 10.1002/uog.154

H. Haber, H. Wollmann, and M. Ranke, Pelvic ultrasonography: Early differentiation between isolated premature thelarche and central precocious puberty, European Journal of Pediatrics, vol.14, issue.3, pp.182-188, 1995.
DOI : 10.1007/BF01954267

M. Chalumeau, C. Hadjiathanasiou, and S. Ng, Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule Etiology and age incidence of precocious puberty in girls: a multicentric study, J Pediatr. J Pediatr Endocrinol Metab, vol.14313, issue.1, pp.445-50695, 2000.

D. Sanctis, V. Corrias, A. Rizzo, and V. , Etiology of Central Precocious Puberty in Males: The Results of the Italian Study Group for Physiopathology of Puberty, Journal of Pediatric Endocrinology and Metabolism, vol.13, issue.Supplement, pp.687-93, 2000.
DOI : 10.1515/JPEM.2000.13.S1.687

F. Antoniazzi and G. Zamboni, Central Precocious Puberty, Pediatric Drugs, vol.84, issue.4, pp.211-242, 2004.
DOI : 10.2165/00148581-200406040-00002

W. Crowley, J. Comite, F. Vale, and W. , THERAPEUTIC USE OF PITUITARY OESENSITIZATION WITH A LONG-ACTING LHRM AGONIST: A POTENTIAL NEW TREATMENT FOR IDIOPATHIC PRECOCIOUS PUBERTY*, The Journal of Clinical Endocrinology & Metabolism, vol.52, issue.2, pp.370-372, 1981.
DOI : 10.1210/jcem-52-2-370

J. Carel, N. Lahlou, and L. Guazzarotti, Treatment of central precocious puberty with depot leuprorelin, European Journal of Endocrinology, vol.132, issue.6, pp.699-704, 1995.
DOI : 10.1530/eje.0.1320699

C. Heinrichs, M. Craen, and M. Vanderschueren-lodeweyckx, Variations in pituitary-gonadal suppression during intranasal buserelin and intramuscular depot-triptorelin therapy for central precocious puberty, Acta Paediatrica, vol.107, issue.Suppl 372, pp.627-660, 1994.
DOI : 10.1111/j.1651-2227.1994.tb13095.x

T. Tuvemo, J. Gustafsson, and L. Proos, Suppression of Puberty in Girls with Short-Acting Intranasal versus Subcutaneous Depot GnRH Agonist, Hormone Research in Paediatrics, vol.57, issue.1-2, pp.27-31, 2002.
DOI : 10.1159/000057943

N. Lahlou, J. Carel, and J. Chaussain, Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics Partsch CJ, Sippell WG. Treatment of central precocious puberty, J Pediatr Endocrinol Metab. Best Practice & Research Clinical Endocrinology & Metabolism, vol.1316, pp.165-89, 2000.

W. Paterson, E. Mcneill, and D. Young, Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty Sequential comparisons of one-month and threemonth depot leuprolide regimens in central precocious puberty, Clin Endocrinol (Oxf). J Clin Endocrinol Metab, vol.6191, pp.626-341862, 2004.

E. Eugster, W. Clarke, and G. Kletter, Efficacy and Safety of Histrelin Subdermal Implant in Children with Central Precocious Puberty: A Multicenter Trial, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.5, pp.1697-704, 2007.
DOI : 10.1210/jc.2006-2479

H. Hirsch, D. Gillis, and D. Strich, The Histrelin Implant: A Novel Treatment for Central Precocious Puberty, PEDIATRICS, vol.116, issue.6, pp.798-802, 2005.
DOI : 10.1542/peds.2005-0538

T. Tanaka, I. Hibi, and K. Kato, A Dose Finding Study of a Super Long-Acting Luteinizing Hormone-Releasing Hormone Analog (Leuprolide Acetate Depot, TAP-144-SR) in the Treatment of Central Precocious Puberty., Endocrinologia Japonica, vol.38, issue.4, pp.369-376, 1991.
DOI : 10.1507/endocrj1954.38.369

E. Neely, R. Hintz, and B. Parker, Two-year results of treatment with depot leuprolide acetate for central precocious puberty, The Journal of Pediatrics, vol.121, issue.4, pp.634-640, 1992.
DOI : 10.1016/S0022-3476(05)81162-X

J. Carel, N. Lahlou, and O. Jaramillo, Treatment of Central Precocious Puberty by Subcutaneous Injections of Leuprorelin 3-Month Depot (11.25 mg), The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.9, pp.4111-4117, 2002.
DOI : 10.1210/jc.2001-020243

J. Carel, J. Blumberg, and C. Seymour, Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty, European Journal of Endocrinology, vol.154, issue.1, pp.119-143, 2006.
DOI : 10.1530/eje.1.02056

J. Carel, N. Lahlou, and M. Roger, Precocious puberty and statural growth, Human Reproduction Update, vol.10, issue.2, pp.135-182, 2004.
DOI : 10.1093/humupd/dmh012

P. Lee, J. Page, and L. Group, Effects of leuprolide in the treatment of central precocious puberty, The Journal of Pediatrics, vol.114, issue.2, pp.321-324, 1989.
DOI : 10.1016/S0022-3476(89)80806-6

P. Manasco, O. Pescovitz, and R. Blizzard, Local reactions to depot leuprolide therapy for central precocious puberty, The Journal of Pediatrics, vol.123, issue.2, pp.334-335, 1993.
DOI : 10.1016/S0022-3476(05)81720-2

C. Roth, Therapeutic potential of GnRH antagonists in the treatment of precocious puberty, Expert Opinion on Investigational Drugs, vol.82, issue.9
DOI : 10.1258/0007142001903346

A. Schultze-mosgau, G. Griesinger, and C. Altgassen, New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists, Expert Opinion on Investigational Drugs, vol.74, issue.9, pp.1085-97, 2005.
DOI : 10.1517/14740338.3.1.39

E. Eugster, Aromatase Inhibitors in Precocious Puberty, Treatments in Endocrinology, vol.88, issue.8, pp.141-51, 2004.
DOI : 10.2165/00024677-200403030-00002

M. Lampit, A. Golander, and H. Guttmann, Estrogen mini-dose replacement during GnRH agonist therapy in central precocious puberty: a pilot study Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone, J Clin Endocrinol Metab. J Clin Endocrinol Metab, vol.8791, pp.687-901284, 2002.

A. Pasquino, I. Pucarelli, and M. Segni, Adult Height in Girls with Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogues and Growth Hormone, The Journal of Clinical Endocrinology & Metabolism, vol.84, issue.2, pp.449-52, 1999.
DOI : 10.1210/jcem.84.2.5431

I. Pucarelli, M. Segni, and M. Ortore, Effects of Combined Gonadotropin-Releasing Hormone Agonist and Growth Hormone Therapy on Adult Height in Precocious Puberty: A Further Contribution, Journal of Pediatric Endocrinology and Metabolism, vol.16, issue.7, pp.1005-1015, 2003.
DOI : 10.1515/JPEM.2003.16.7.1005

W. Oostdijk, B. Rikken, and S. Schreuder, Final height in central precocious puberty after long term treatment with a slow release GnRH agonist., Archives of Disease in Childhood, vol.75, issue.4, pp.292-297, 1996.
DOI : 10.1136/adc.75.4.292

T. Tanaka, H. Niimi, and N. Matsuo, Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function, J Clin Endocrinol Metab. J Clin Endocrinol Metab, vol.9093, pp.1371-6190, 2005.

F. Antoniazzi, T. Arrigo, and M. Cisternino, End Results in Central Precocious Puberty with GnRH Analog Treatment: The Data of the Italian Study Group for Physiopathology of Puberty, Journal of Pediatric Endocrinology and Metabolism, vol.13, issue.Supplement, pp.773-80, 2000.
DOI : 10.1515/JPEM.2000.13.S1.773

D. Mul, W. Oostdijk, and B. Otten, Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience Treatment of central precocious puberty: lessons from a 15 years prospective trial. German Decapeptyl Study Group, J Pediatr Endocrinol Metab. J Pediatr Endocrinol Metab, vol.1313, issue.72 1, pp.765-72747, 2000.

A. Cassio, E. Cacciari, and A. Balsamo, Randomised trial of LHRH analogue treatment on final Page, p.32

A. Cassio, M. Bal, and L. Orsini, Reproductive outcome in patients treated and not treated for idiopathic early puberty: Long-term results of a randomized trial in adults, The Journal of Pediatrics, vol.149, issue.4, pp.532-538, 2006.
DOI : 10.1016/j.jpeds.2006.05.026

P. Feuillan, J. Jones, and K. Barnes, Reproductive Axis after Discontinuation of Gonadotropin-Releasing Hormone Analog Treatment of Girls with Precocious Puberty: Long Term Follow-Up Comparing Girls with Hypothalamic Hamartoma to Those with Idiopathic Precocious Puberty, The Journal of Clinical Endocrinology & Metabolism, vol.84, issue.1, pp.44-49, 1999.
DOI : 10.1210/jcem.84.1.5409

T. Arrigo, D. Luca, F. Antoniazzi, and F. , Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment, European Journal of Pediatrics, vol.13, issue.3, pp.73-77, 2007.
DOI : 10.1007/s00431-006-0207-z

S. Heger, M. Muller, and M. Ranke, Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy, Mol Cell Endocrinol, vol.254, 2006.

S. Bertelloni, G. Baroncelli, and M. Ferdeghini, Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues, European Journal of Pediatrics, vol.159, issue.5, pp.369-74, 2000.
DOI : 10.1007/s004310051289

M. Palmert, M. Mansfield, and W. Crowley, Is obesity an outcome of gonadotropinreleasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy, J Clin Endocrinol Metab. J Clin Endocrinol Metab, vol.8487, issue.81, pp.4480-8506, 1999.

F. Antoniazzi, G. Zamboni, and F. Bertoldo, Bone Mass at Final Height in Precocious Puberty after Gonadotropin-Releasing Hormone Agonist with and without Calcium Supplementation, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.3, pp.1096-101, 2003.
DOI : 10.1210/jc.2002-021154

T. Arrigo, D. Luca, F. Antoniazzi, and F. , Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty, European Journal of Endocrinology, vol.150, issue.4, pp.533-540, 2004.
DOI : 10.1530/eje.0.1500533

A. Messaaoui, G. Massa, and S. Tenoutasse, Treatment of central precocious puberty with Gonadotropin-Releasing Hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after treatment], Rev Med Brux, vol.26, pp.27-32, 2005.

C. Traggiai, P. Perucchin, and K. Zerbini, Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height, European Journal of Endocrinology, vol.153, issue.3
DOI : 10.1530/eje.1.01975

L. Lazar, R. Kauli, and A. Pertzelan, Gonadotropin-Suppressive Therapy in Girls with Early and Fast Puberty Affects the Pace of Puberty but Not Total Pubertal Growth or Final Height, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.5, pp.2090-2094, 2002.
DOI : 10.1210/jcem.87.5.8481

S. Bertelloni, G. Baroncelli, and M. Sorrentino, Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females, European Journal of Pediatrics, vol.3, issue.5
DOI : 10.1007/s004310050831

M. Escobar, M. Ropelato, and M. Ballerini, Acceleration of Luteinizing Hormone Pulse Frequency in Adolescent Girls with a History of Central Precocious Puberty with versus without Hyperandrogenism, Hormone Research in Paediatrics, vol.68, issue.6, pp.278-285, 2007.
DOI : 10.1159/000104177

M. Cisternino, A. Pasquino, and M. Bozzola, Final Height Attainment and Gonadal Function in Girls with Precocious Puberty Treated with Cyproterone Acetate, Hormone Research, vol.37, issue.3, pp.86-90, 1992.
DOI : 10.1159/000182288

M. Palmert, D. Hayden, and M. Mansfield, The Longitudinal Study of Adrenal Maturation during Gonadal Suppression: Evidence That Adrenarche Is a Gradual Process, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.9, pp.4536-4578, 2001.
DOI : 10.1210/jcem.86.9.7863

A. Jensen, V. Brocks, and K. Holm, Central precocious puberty in girls: Internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues, The Journal of Pediatrics, vol.132, issue.1, pp.105-113, 1998.
DOI : 10.1016/S0022-3476(98)70493-7

R. Rosenfield, Identifying Children at Risk for Polycystic Ovary Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.3, pp.787-796, 2007.
DOI : 10.1210/jc.2006-2012

L. Lazar, R. Kauli, and C. Bruchis, High prevalence of abnormal adrenal response in girls with central precocious puberty at early pubertal stages, European Journal of Endocrinology, vol.133, issue.4, pp.407-418, 1995.
DOI : 10.1530/eje.0.1330407

L. Lazar, R. Kauli, and C. Bruchis, Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response, European Journal of Endocrinology, vol.133, issue.4, pp.403-409, 1995.
DOI : 10.1530/eje.0.1330403

L. Steinberg and A. Morris, Adolescent Development, Annual Review of Psychology, vol.52, issue.1, pp.83-110, 2001.
DOI : 10.1146/annurev.psych.52.1.83

K. Weichold, R. Silbereisen, and E. Schmitt-rodermund, Short-and long-term consequences of early versus late physical maturation in adolescents Puberty and psychopathology, pp.241-276, 2003.

E. Susman and A. Rogol, Puberty and psychological development Handbook of adolescent psychology, pp.15-44, 2004.

C. Sisk and J. Zehr, Pubertal hormones organize the adolescent brain and behavior, Frontiers in Neuroendocrinology, vol.26, issue.3-4, pp.163-174, 2005.
DOI : 10.1016/j.yfrne.2005.10.003

L. Dorn, Psychological and social problems in children with premature adrenarche and precocious puberty When puberty is precocious: Scientific and clinical aspects, pp.309-327, 2007.

D. Xhrouet-heinrichs, K. Lagrou, and C. Heinrichs, Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long-acting triptorelin therapy, Acta Paediatrica, vol.142, issue.Suppl 2, pp.808-823, 1997.
DOI : 10.1111/j.1651-2227.1997.tb08602.x

P. Pacheco, B. , M. Ribas, J. Milone, and G. , Use of GnRH Analogs for Functional Protection of the Ovary and Preservation of Fertility during Cancer Treatment in Adolescents: A Preliminary Report, Gynecologic Oncology, vol.81, issue.3, pp.391-398, 2001.
DOI : 10.1006/gyno.2001.6181

J. Waxman, R. Ahmed, and D. Smith, Failure to preserve fertility in patients with Hodgkin's disease, Cancer Chemotherapy and Pharmacology, vol.19, issue.2, pp.159-62, 1987.
DOI : 10.1007/BF00254570

S. Lee, L. Schover, and A. Partridge, American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients, Journal of Clinical Oncology, vol.24, issue.18, pp.2917-2948, 2006.
DOI : 10.1200/JCO.2006.06.5888

F. Antoniazzi, M. Cisternino, and G. Nizzoli, Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments, Acta Paediatrica, vol.122, issue.10, pp.1052-1056, 1994.
DOI : 10.1016/S0022-3476(05)81074-1

J. Carel, F. Hay, and R. Coutant, Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development, Journal of Clinical Endocrinology & Metabolism, vol.81, issue.9, pp.3318-3322, 1996.
DOI : 10.1210/jc.81.9.3318

C. Bouvattier, J. Coste, and D. Rodrigue, Lack of Effect of GnRH Agonists on Final Height in Girls with Advanced Puberty: A Randomized Long-Term Pilot Study, The Journal of Clinical Endocrinology & Metabolism, vol.84, issue.10, pp.3575-3578, 1999.
DOI : 10.1210/jcem.84.10.6032

J. Yanovski, S. Rose, and G. Municchi, Treatment with a Luteinizing Hormone???Releasing Hormone Agonist in Adolescents with Short Stature, New England Journal of Medicine, vol.348, issue.10, pp.908-925, 2003.
DOI : 10.1056/NEJMoa013555

R. Lanes, A. Soros, and S. Jakubowicz, Accelerated Versus Slowly Progressive Forms of Puberty in Girls with Precocious and Early Puberty. Gonadotropin Suppressive Effect and Final Height Obtained with Two Different Analogs, Journal of Pediatric Endocrinology and Metabolism, vol.17, issue.5, pp.759-66, 2004.
DOI : 10.1515/JPEM.2004.17.5.759

T. Tuvemo, Treatment of central precocious puberty, Expert Opinion on Investigational Drugs, vol.64, issue.5, pp.495-505, 2006.
DOI : 10.1530/eje.0.151U101

J. Carel, Management of short stature with GnRH agonist and co-treatment with growth hormone: A controversial issue, Molecular and Cellular Endocrinology, vol.254, issue.255, pp.254-255226, 2006.
DOI : 10.1016/j.mce.2006.04.034

A. Pasquino, I. Pucarelli, and M. Roggini, Adult Height in Short Normal Girls Treated with Gonadotropin-Releasing Hormone Analogs and Growth Hormone, The Journal of Clinical Endocrinology & Metabolism, vol.85, issue.2, pp.619-622, 2000.
DOI : 10.1210/jcem.85.2.6387

S. Van-gool, G. Kamp, and H. Visser-van-balen, Final Height Outcome after Three Years of Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Short Adolescents with Relatively Early Puberty, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.4, pp.1402-1410, 2007.
DOI : 10.1210/jc.2006-2272

D. Mul, W. Oostdijk, and J. Waelkens, Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone, Clinical Endocrinology, vol.348, issue.4, pp.185-90, 2005.
DOI : 10.1046/j.1365-2265.2001.01315.x

P. Clayton, S. Cianfarani, and P. Czernichow, Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.3, pp.804-814, 2007.
DOI : 10.1210/jc.2006-2017

L. Teng, H. Bui, and L. Bachrach, Catch-up Growth in Severe Juvenile Hypothyroidism: Treatment with a GnRH Analog, Journal of Pediatric Endocrinology and Metabolism, vol.17, issue.3, pp.345-54, 2004.
DOI : 10.1515/JPEM.2004.17.3.345

J. Carel, E. Ecosse, and M. Nicolino, Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry, BMJ, vol.325, issue.7355, pp.70-73, 2002.
DOI : 10.1136/bmj.325.7355.70

E. Reiter, A. Lindberg, and M. Ranke, The KIGS Experience with the Addition of Gonadotropin-Releasing Hormone Agonists to Growth Hormone (GH) Treatment of Children with Idiopathic GH Deficiency, Hormone Research in Paediatrics, vol.60, issue.1, pp.68-73, 2003.
DOI : 10.1159/000071229

D. Mul, J. Wit, and W. Oostdijk, The Effect of Pubertal Delay by GnRH Agonist in GH-Deficient Children on Final Height, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.10, pp.4655-4661, 2001.
DOI : 10.1210/jcem.86.10.7910

M. Mericq, M. Eggers, and A. Avila, Near Final Height in Pubertal Growth Hormone (GH)-Deficient Patients Treated with GH Alone or in Combination with Luteinizing Hormone-Releasing Hormone Analog: Results of a Prospective, Randomized Trial, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.2, pp.569-73, 2000.
DOI : 10.1210/jc.85.2.569

G. Saggese, G. Federico, and S. Barsanti, The Effect of Administering Gonadotropin-Releasing Hormone Agonist with Recombinant-Human Growth Hormone (GH) on the Final Height of Girls with Isolated GH Deficiency: Results from a Controlled Study, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.5, pp.1900-1904, 2001.
DOI : 10.1210/jcem.86.5.7439

T. Tanaka, M. Satoh, and T. Yasunaga, When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue, Acta Paediatrica, vol.10, issue.s428, pp.85-93, 1999.
DOI : 10.1159/000023131

V. Mericq, H. Gajardo, and M. Eggers, Effects of Treatment with GH Alone or in Combination with LHRH Analog on Bone Mineral Density in Pubertal GH-Deficient Patients, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.1, pp.84-93, 2002.
DOI : 10.1210/jcem.87.1.8148

K. Lin-su, M. Vogiatzi, and I. Marshall, Treatment with Growth Hormone and Luteinizing Hormone Releasing Hormone Analog Improves Final Adult Height in Children with Congenital Adrenal Hyperplasia, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.6, pp.3318-3343, 2005.
DOI : 10.1210/jc.2004-2128

D. Geier and M. Geier, A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders, Neuro Endocrinol Lett, vol.27, pp.833-841, 2006.